Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arvind Sahu

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Frontiers in Oncology|September 16, 2021
Immune Checkpoint Inhibitor in First-Line Treatment of Metastatic Renal Cell Carcinoma: A Review of Current Evidence and Future DirectionsIris Tung, Arvind Sahu
Journal of Gastrointestinal Oncology|May 13, 2022
The treatment of resectable gastric cancer: a literature review of an evolving landscapeIris Tung, Arvind Sahu
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2010
Identification of Complin, a novel complement inhibitor that targets complement proteins factor B and C2Archana P Kadam, Arvind Sahu
Journal of Gastrointestinal Oncology|June 11, 2016
Dihydro pyrimidine dehydrogenase deficiency in patients treated with capecitabine based regimens: a tertiary care centre experienceArvind Sahu, Anant Ramaswamy, Vikas Ostwal
Trends in Immunology|September 12, 2003
Herpes and pox viral complement control proteins: 'the mask of self'Jayati Mullick, Archana Kadam, Arvind Sahu
Frontiers in Oncology|March 11, 2026
Adherence to adjuvant endocrine therapy in breast cancer: a single regional Australian centre experienceDianheng Bu, Arvind Sahu, Javier Torres
Molecular Immunology|November 15, 2002
Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3Arvind Sahu, Dimitrios Morikis, John D Lambris
Frontiers in Oncology|July 5, 2021
Real-World Data on Outcomes in Metastatic Castrate-Resistant Prostate Cancer Patients Treated With Abiraterone or Enzalutamide: A Regional ExperienceRachel Raju, Arvind Sahu, Myron Klevansky, et al.
Molecular Immunology|July 6, 2021
Differential expression of complement receptors CR1/2 and CR4 by murine M1 and M2 macrophagesArya Ghate, Samriddhi Sharma, Palak Agrawal, et al.
Indian Journal of Biochemistry & Biophysics|March 18, 2008
Viral complement regulators: the expert mimicking swindlersMuzammil Ahmad, Kalyani Pyaram, Jayati Mullick, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|September 16, 2021
Immune Checkpoint Inhibitor in First-Line Treatment of Metastatic Renal Cell Carcinoma: A Review of Current Evidence and Future DirectionsIris Tung, Arvind Sahu
Journal of Gastrointestinal Oncology|May 13, 2022
The treatment of resectable gastric cancer: a literature review of an evolving landscapeIris Tung, Arvind Sahu
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2010
Identification of Complin, a novel complement inhibitor that targets complement proteins factor B and C2Archana P Kadam, Arvind Sahu
Journal of Gastrointestinal Oncology|June 11, 2016
Dihydro pyrimidine dehydrogenase deficiency in patients treated with capecitabine based regimens: a tertiary care centre experienceArvind Sahu, Anant Ramaswamy, Vikas Ostwal
Trends in Immunology|September 12, 2003
Herpes and pox viral complement control proteins: 'the mask of self'Jayati Mullick, Archana Kadam, Arvind Sahu
Frontiers in Oncology|March 11, 2026
Adherence to adjuvant endocrine therapy in breast cancer: a single regional Australian centre experienceDianheng Bu, Arvind Sahu, Javier Torres
Molecular Immunology|November 15, 2002
Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3Arvind Sahu, Dimitrios Morikis, John D Lambris
Frontiers in Oncology|July 5, 2021
Real-World Data on Outcomes in Metastatic Castrate-Resistant Prostate Cancer Patients Treated With Abiraterone or Enzalutamide: A Regional ExperienceRachel Raju, Arvind Sahu, Myron Klevansky, et al.
Molecular Immunology|July 6, 2021
Differential expression of complement receptors CR1/2 and CR4 by murine M1 and M2 macrophagesArya Ghate, Samriddhi Sharma, Palak Agrawal, et al.
Indian Journal of Biochemistry & Biophysics|March 18, 2008
Viral complement regulators: the expert mimicking swindlersMuzammil Ahmad, Kalyani Pyaram, Jayati Mullick, et al.
Pageof 8